Research
Epitranscriptomics & Cancer Adaptation : A.David

Rodrigues M, Quesada S The SFC in 2025, almost 120 years old and still full of new projects. 2025-01-10 00:00:00. doi:10.1016/j.bulcan.2024.12.008

Michele M, Attina A, Roux P-F, Laguesse S, Florido J, Houdeville M, Choquet A, Encislai B, Arena G, Blasio C, Wendling O, Frenois F-X, Papon L, Stuani L, Fuentes M, Talignani C, Rousseau M, Guégan J, Buscail Y, Dupré P, Michaud H-A, Rodier G, Bellvert F, Kulyk H, Peyret C, Mathieu H, Close P, Rapino F, Chaveroux C, Pirot N, Rubio L, Torro A, Sorg T, Ango F, Hirtz C, Compan V, Lebigot E, Legati A, Ghezzi D, Nguyen L, David A, Sardet C, Lacroix M, Cam L E4F1 coordinates pyruvate metabolism and the activity of the elongator complex to ensure translation fidelity during brain development. 2025-01-02 00:00:00. doi:10.1038/s41467-024-55444-y

Eldin P, David A, Hirtz C, Battini J-L, Briant L SARS-CoV-2 Displays a Suboptimal Codon Usage Bias for Efficient Translation in Human Cells Diverted by Hijacking the tRNA Epitranscriptome. 2024-11-09 00:00:00. doi:10.3390/ijms252111614

Sahu A, Shah R, Nashier D, Sharma P, Varada R, Lahry K, Singh S, Shetty S, Hussain T, Varshney U Physiological significance of the two isoforms of initiator tRNAs in Escherichia coli. 2024-08-22 00:00:00. doi:10.1128/jb.00251-24

Seedhom M, Dersh D, Holly J, Pavon-Eternod M, Wei J, Angel M, Shores L, David A, Santos J, Hickman H, Yewdell J Paradoxical imbalance between activated lymphocyte protein synthesis capacity and rapid division rate. 2024-03-21 00:00:00. doi:10.7554/eLife.89015

M'Baloula J, Tougeron D, Jeanbert E, Guimbaud R, Abdelghani M, Durand A, Turpin A, Quesada S, Blanc J, Artru P, Toullec C, Trouilloud I, Pellat A, Touchefeu Y, Pinot J, Caroli-Bosc F-X, Doat S, Bouché O, Védie A, Mestier L, Muller M Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study. 2024-10-04 00:00:00. doi:10.1016/j.ejca.2024.115051

Amalric A, Attina A, Bastide A, Buffard M, Mateus S, Planque C, Rivals E, Hirtz C, David A Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation. Anal Chem. 2024;96(5):1825-1833. doi:10.1021/acs.analchem.3c02635

Truffinet F, Arco-Hierves A, Shalabi H, Pascaud J, Mazet P, Rivière E, Silva-Saffar S, Fabbri L, Leboucher S, Besse L, Messaoudi C, Attina A, David A, Nocturne G, Mariette X, Bechara R m6A RNA methylation controls salivary gland epithelial cell function and has a protective role in Sjögren's disease. 2024-09-19 00:00:00. doi:10.1136/ard-2024-226224

Joly F, Bazan F, Decoopman D, Ouldbey Y, Follana P, Champeaux-Orange É, Legouffe E, Brachet P-E, Combe P, Hardy-Bessard A-C, Selle F, Grenier J, Lebreton C, Derbel O, Bonnet E, Fournel P, Diez Y, Delecroix V, Emambux S, Alexandre J, Grellety T, Mille D, Orfeuvre H, Favier C, Roux D, Mouret-Reynier M-A, Quesada S, Kurtz J-E Improving real-world evaluation of patient- and physician-reported tolerability: niraparib for recurrent ovarian cancer (NiQoLe). 2024-12-14 00:00:00. doi:10.1093/jncics/pkae114

Colombo P-E, Taoum C, Fabbro M, Quesada S, Rouanet P, Ray-Coquard I Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer. 2024-08-07 00:00:00. doi:10.1016/j.critrevonc.2024.104469

Quesada S, Penault-Llorca F, Matias-Guiu X, Banerjee S, Barberis M, Coleman R, Colombo N, DeFazio A, McNeish I, Nogueira-Rodrigues A, Oaknin A, Pignata S, Ry?ka A, Merwe N, Gorp T, Vergote I, Weichert W, Wu X, Ray-Coquard I, Pujol P, group e Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics. 2024-12-18 00:00:00. doi:10.1016/j.ejca.2024.115169

Lahry K, Datta M, Varshney U Genetic analysis of translation initiation in bacteria: An initiator tRNA-centric view. 2024-02-27 00:00:00. doi:10.1111/mmi.15243

Chatelet C, Quesada S Fruquintinib for patients with metastatic colorectal cancer previously treated with standard treatments. 2024-10-25 00:00:00. doi:10.1016/j.bulcan.2024.08.018

Bruciamacchie M, Garambois V, Vie N, Bessede T, Michaud H-A, Gros L, Bonnefoy N, Robin M, Brager D, Bigot K, Evrard A, Pourquier P, Colinge J, Mathonnet M, Belhabib I, Jean C, Bousquet C, Colombo P-E, Jarlier M, Gongora C, Larbouret C ATR inhibition potentiates FOLFIRINOX cytotoxic effect in models of pancreatic ductal adenocarcinoma by remodelling the tumour microenvironment. 2024-11-29 00:00:00. doi:10.1038/s41416-024-02904-3

Quesada S, Lebreton C, Caux C, Italiano A, Dubois B [Tertiary lymphoid structures in cancer: From biology to therapeutic guides]. Bull Cancer. 2023;110(6):657-664. doi:10.1016/j.bulcan.2023.04.010

Dussart C, Decaux-Tramoni B, Quesada S, Thomas Q, Benzerouale O, Nicolas E [Combination strategies for checkpoint inhibition: Current practices and perspectives]. Bull Cancer. 2023;110(7-8):790-801. doi:10.1016/j.bulcan.2023.03.021

Lebreton C, Quesada S, Bini M, Babin G, Rossi L, Chopin N, Croce S, Hartog C, Renaud T, Gaillard A-L, Petit A, Serre A-A, Rowinski E, Cockenpot V, Treilleux I, Rousset-Jablonski C, Guyon F, Ray-Coquard I Treatments for rare ovarian tumors: What's new?. 2023-04-12 00:00:00. doi:10.1016/j.bulcan.2023.03.007

Quesada S, Jacot W The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile?. Ann Transl Med. 2023;11(11):393. doi:10.21037/atm-23-1608

Chevalier C, Dorignac J, Ibrahim Y, Choquet A, David A, Ripoll J, Rivals E, Geniet F, Walliser N-O, Palmeri J, Parmeggiani A, Walter J-C Physical modeling of ribosomes along messenger RNA: Estimating kinetic parameters from ribosome profiling experiments using a ballistic model. 2023-10-20 00:00:00. doi:10.1371/journal.pcbi.1011522

Quesada S, Thomas Q, Colombo P-E, Fiteni F Optimal First-Line Medico-Surgical Strategy in Ovarian Cancers: Are We There Yet?. Cancers (Basel). 2023;15(14):3556. doi:10.3390/cancers15143556

Montacié C, Riondet C, Wei L, Darrière T, Weiss A, Pontvianne F, Escande M-L, Bures A, Jobet E, Barbarossa A, Carpentier M-C, Aarts M, Attina A, Hirtz C, David A, Marchand V, Motorin Y, Curie C, Mari S, Reichheld J-P, Sáez-Vásquez J NICOTIANAMINE SYNTHASE activity affects nucleolar iron accumulation and impacts rDNA silencing and RNA methylation in Arabidopsis. 2023-05-14 00:00:00. doi:10.1093/jxb/erad180

Vignon M, Bastide A, Attina A, David A, Bousquet P, Orti V, Vialaret J, Lehmann S, Periere D, Hirtz C Multiplexed LC-MS/MS quantification of salivary RNA modifications in periodontitis. J Periodontal Res. 2023;58(5):959-967. doi:10.1111/jre.13155

Singh S, Lahry K, Mandava C, Singh J, Shah R, Sanyal S, Varshney U Lamotrigine compromises the fidelity of initiator tRNA recruitment to the ribosomal P-site by IF2 and the RbfA release from 30S ribosomes in Escherichia coli. 2023-09-07 00:00:00. doi:10.1080/15476286.2023.2253395

Rabehi T, Quesada S Ivosidenib in the treatment of patients with cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy. 2023-09-13 00:00:00. doi:10.1016/j.bulcan.2023.05.003

Quesada S, Solassol J, Ray-Coquard I, Fabbro M Homologous recombination deficiency in epithelial ovarian cancers: from molecular characterization to patient journey. 2023-03-02 00:00:00. doi:10.1016/j.bulcan.2023.02.004



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés